A role for fulvestrant monotherapy in the first-line treatment of ER+ metastatic breast cancer?

Breast J. 2020 Feb;26(2):109-111. doi: 10.1111/tbj.13495. Epub 2019 Sep 20.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Agents, Hormonal
  • Breast Neoplasms*
  • Fulvestrant
  • Humans
  • Receptors, Estrogen

Substances

  • Antineoplastic Agents, Hormonal
  • Receptors, Estrogen
  • Fulvestrant